Human and mammal cell expression vector and application thereof

An expression vector and mammalian technology, applied in the field of genetic engineering, can solve problems such as unsatisfactory expression levels of transgenes, and achieve the effect of increasing expression and increasing expression levels

Active Publication Date: 2014-03-19
河南普诺易生物制品研究院有限公司 +1
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, MAR is still suboptimal in i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human and mammal cell expression vector and application thereof
  • Human and mammal cell expression vector and application thereof
  • Human and mammal cell expression vector and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0022] Example 1 Construction of expression vector pCAD

[0023] 1.1 Construction of expression vector pCATG containing neomycin eukaryotic resistance gene selection complex

[0024] 1.1.1 PCR amplification of neomycin eukaryotic resistance gene selection complex

[0025] According to the sequence of the neomycin eukaryotic resistance gene selection complex (GenBank accession number is EF437957.1), the primers P1 and P2 were designed, and the 5′ ends of the primers were introduced into Sal I restriction sites respectively. The primer sequences are as follows (the underline is the restriction site Point): P1: 5′-GTC GTCGAC CTGTGGAATGTGTGTCAGTTAGGGTGTGGA-3′; P2: 5′-AGC GTCGAC CAGACATGATAAGATACATTGATGAGA-3'. Using the extracted pCDNA3.1 plasmid as a template, primers P1 and P2 were used to amplify the sequence of the neomycin eukaryotic resistance gene selection complex, and the conventional PCR method was used for amplification. The PCR system is shown in Table 1.

[0026] Table 1 P...

Example Embodiment

[0036] Example 2 Construction of expression vectors pCAC1 and pCAC2

[0037] 1.2.1 PCR amplification of DNA fragments of different sizes

[0038] Refer to the enhanced green fluorescent protein (EGFP) gene fragment sequence of pEGFP-C1 vector (GenBank accession number is U55763.1) to design the following primers: P5:5′-CCGGCTAGCGCTACCGGTCGCCA-3′;P6:5′-CGCAGATCTCTGAGTGCGGACTTG-3′;P7 : 5'-AATAGATCTCGGCGCGGGTCTTGTA-3'. P5 and P6 are used to amplify 750 bp fragments, P5 and P7 are used to amplify 350 bp fragments, while introducing Bgl II / Nhe Ⅰ restriction sites, using the extracted pEGFP-C1 plasmid as a template, the PCR reaction system is the same as before, PCR The reaction conditions are as follows: 95°C for 3min; 94°C for 40s, 60-56°C for 30s, 72°C for 40s, 4 cycles per annealing temperature, and finally 55°C for 30 cycles; 72°C for 3min. The amplified products were recovered by agarose gel electrophoresis and sent to the biological company for sequencing verification. The resu...

Example Embodiment

[0041] Example 3 Expression of VEGF gene in Chinese hamster ovary (CHO) cells using the expression vector of the present invention

[0042] (1) Construction of pCAD-VEGF vector containing vascular endothelial growth factor (VEGF)

[0043] The PCR primers P8 and P9 were designed according to the human VEGF gene cDNA sequence (GenBank accession number is AF022375.1). In order to achieve directional cloning, NcoI / XbaI restriction sites were introduced at the 5'end of the primers. The primer sequence is as follows: P8: 5′-GGC CCATGG ATGAACTTTCTGCTGTCTTGGGTG-3′; P9: 5′-GCG AAGCTT TCACCGCCTCGGCTTGTCACATCTG-3'. Take fetal myocardial tissue, extract total RNA by Trizol method, and verify its integrity by 1% formaldehyde denaturation agarose gel electrophoresis. In a 25μl reaction system, add RNA 1μg, dNTP 1μl (10mmol / L), P8 and P9 primers at a concentration of 20μmol / L 1μl each, AMV-Taq DNA polymerase 1μl (5U / μl) and AMV reverse transcriptase 1μl (5U / μl), follow the One Step PCR Kit (...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a human and mammal cell expression vector and application thereof. A nucleotide sequence of the expression vector is shown in Seq ID. No.1 or Seq ID No.2; the expression vector is the expression vector built by taking pCAT3-control as a starting vector. By adopting the expression vector disclosed by the invention, the expression level of the carried target gene can be significantly improved, and compared with the expression vector which contains MAR (matrix attachment region) and does not contain EGFP (enhanced green fluorescence protein), expression of the target gene can be significantly improved under the same conditions.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a human and mammalian cell expression vector and its application. Background technique [0002] Gene engineering, also known as recombinant DNA technology, is based on scientific research or production needs, at the molecular level, using artificial methods to extract or synthesize the genetic material (DNA fragments) of different organisms, cutting and splicing in vitro to form recombinant DNA, Then the recombinant DNA is recombined with the vector, and then introduced into the recipient cells without the DNA, replicated and expressed, to produce products that meet human needs or create new biological traits, and make them stably inherited to the next generation. According to the cloning and expression system of the target gene, it can be divided into prokaryotic genetic engineering, plant genetic engineering, animal genetic engineering and yeast genetic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/85C12N15/66
Inventor 张俊河王天云董卫华王芳赵春澎柴树洁王小引王俐杨瑞李琴
Owner 河南普诺易生物制品研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products